CDW Corp
- Market cap
- 17.10B
- P/E (TTM)i
- 16.44
- P/Bi
- 7.00
- EPSi
- 8.08
- Div yieldi
- 1.84%
- 52W posi
- 66%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 112.35% +0.25pp
- Institutions
- 934 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 43 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Christine Leahy | Chairperson & CEO | 0.12% |
| Elizabeth Connelly | Senior Vice President of Healthcare | 0.03% |
| Frederick Kulevich | Senior Vice President | 0.02% |
| Albert Miralles | Senior Vice President | 0.02% |
| Sona Chawla | Chief Growth & Innovation Officer | 0.01% |
| David Nelms | Lead Independent Director | 0.01% |
| Lynda Clarizio | Independent Director | 0.01% |
| Joseph Swedish | Independent Director | 0.01% |
| Katherine Sanderson | Chief Human Resources Officer & Executive VP Coworker Success | 0.01% |
| Donna Zarcone | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | David Nelms | Lead Independent Director | Other Acquisition | +258 | -- |
| 2026-09-30 | Joseph Swedish | Independent Director | Other Acquisition | +212 | -- |
| 2026-09-23 | Katherine Sanderson | Chief Human Resources Officer & Executive VP Coworker Success | Sale to Issuer | -231 | $153.74 |
| 2026-09-09 | David Nelms | Lead Independent Director | Other Acquisition | +147 | $142.60 |
| 2026-09-09 | Marc Jones | Independent Director | Other Acquisition | +19 | $142.60 |
| 2026-09-09 | Christine Leahy | Chairperson & CEO | Other Acquisition | +825 | $142.60 |
| 2026-09-09 | Joseph Swedish | Independent Director | Other Acquisition | +29 | $142.60 |
| 2026-09-09 | James Bell | Independent Director | Other Acquisition | +95 | $142.60 |
| 2026-09-09 | Lynda Clarizio | Independent Director | Other Acquisition | +7 | $142.60 |
| 2026-09-09 | Kelly Grier | Director | Other Acquisition | +7 | $142.60 |
| 2026-09-09 | Virginia Addicott | Independent Director | Other Acquisition | +82 | $142.60 |
| 2026-09-09 | Albert Miralles | Senior Vice President | Other Acquisition | +299 | $142.60 |
| 2026-09-09 | Anthony Foxx | Independent Director | Other Acquisition | +29 | $142.60 |
| 2026-09-09 | Peter Locy | Chief Accounting Officer | Other Acquisition | +29 | $142.60 |
| 2026-09-09 | Frederick Kulevich | Senior Vice President | Other Acquisition | +184 | $142.60 |
| 2026-09-09 | Elizabeth Connelly | Senior Vice President of Healthcare | Other Acquisition | +237 | $142.60 |
| 2026-09-09 | Katherine Sanderson | Chief Human Resources Officer & Executive VP Coworker Success | Other Acquisition | +243 | $142.60 |
| 2026-09-09 | Mukesh Kumar | Chief Services and Solutions Officer | Other Acquisition | +192 | $142.60 |
| 2026-09-09 | Hang Tan | Chief Strategy & Transformation Officer | Other Acquisition | +212 | $142.60 |
| 2026-08-16 | Mukesh Kumar | Chief Services and Solutions Officer | Sale to Issuer | -1,147 | $139.42 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:38:26 · For reference only, not investment advice and not tailored to your situation.